Fusion and connection of classical and new chemical modalities for ‘undruggable’ targets
Cancelled
Event details
| Date | 26.02.2018 |
| Hour | 17:00 › 18:00 |
| Speaker | Dr. Eric Valeur, AstraZeneca |
| Location | |
| Category | Conferences - Seminars |
Eric Valeur is Associate Director for New Modalities at AstraZeneca. He is driving research within the chemical space at the interface of small and large molecules. His present research interests include small molecules, peptides, macrocycles, oligonucleotides and conjugates thereof.
Links
Practical information
- Informed public
- Free
Organizer
- Christian Heinis